Related references
Note: Only part of the references are listed.Exploring the Potential of Monoclonal Antibody Therapeutics for HIV-1 Eradication
Zelda Euler et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2015)
Passively Acquired Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity in HIV-Infected Infants Is Associated with Reduced Mortality
Caitlin Milligan et al.
CELL HOST & MICROBE (2015)
Prospects for engineering HIV-specific antibodies for enhanced effector function and half-life
Austin W. Boesch et al.
CURRENT OPINION IN HIV AND AIDS (2015)
Machine Learning Methods Enable Predictive Modeling of Antibody Feature: Function Relationships in RV144 Vaccinees
Ickwon Choi et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
Independent evolution of Fc- and Fab-mediated HIV-1-specific antiviral antibody activity following acute infection
Anne-Sophie Dugast et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Divergent Antibody Subclass and Specificity Profiles but Not Protective HLA-B Alleles Are Associated with Variable Antibody Effector Function among HIV-1 Controllers
Jennifer I. Lai et al.
JOURNAL OF VIROLOGY (2014)
Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines
Amy W. Chung et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination
Nicole L. Yates et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys
Dan H. Barouch et al.
CELL (2013)
Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity
Margaret E. Ackerman et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Enhanced Phagocytic Activity of HIV-Specific Antibodies Correlates with Natural Production of Immunoglobulins with Skewed Affinity for FcγR2a and FcγR2b
Margaret E. Ackerman et al.
JOURNAL OF VIROLOGY (2013)
High Antibody-Dependent Cellular Cytotoxicity Responses Are Correlated with Strong CD8 T Cell Viral Suppressive Activity but Not with B57 Status in HIV-1 Elite Controllers
Olivier Lambotte et al.
PLOS ONE (2013)
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
Georgia D. Tomaras et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
Asier Saez-Cirion et al.
PLOS PATHOGENS (2013)
High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samples
Eric P. Brown et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2012)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
HIV-Specific Antibodies Capable of ADCC Are Common in Breastmilk and Are Associated with Reduced Risk of Transmission in Women with High Viral Loads
Jennifer Mabuka et al.
PLOS PATHOGENS (2012)
Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection
Nicole L. Yates et al.
AIDS (2011)
A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples
Margaret E. Ackerman et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection
Laurent Hocqueloux et al.
AIDS (2010)
Regularization Paths for Generalized Linear Models via Coordinate Descent
Jerome Friedman et al.
JOURNAL OF STATISTICAL SOFTWARE (2010)
Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy
Florencia Pereyra et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Cellular and humoral responses to tetanus vaccination in gabonese children
E. van Riet et al.
VACCINE (2008)
A whole-genome association study of major determinants for host control of HIV-1
Jacques Fellay et al.
SCIENCE (2007)
The neutralization properties of a HIV-specific antibody are markedly altered by glycosylation events outside the antigen-binding domain
Luis R. Miranda et al.
JOURNAL OF IMMUNOLOGY (2007)
A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity
VR Gómez-Román et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2006)
Detection of antibody-dependent complement-mediated inactivation of both autologous and heterologous virus in primary human immunodeficiency virus type I infection
MMI Aasa-Chapman et al.
JOURNAL OF VIROLOGY (2005)
Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251
VR Gómez-Román et al.
JOURNAL OF IMMUNOLOGY (2005)
Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120
FB Liu et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2003)
Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1
O Scharf et al.
JOURNAL OF VIROLOGY (2001)
The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection
F García et al.
AIDS (2001)
Evidence for a correlation between antibody-dependent cellular cytotoxicity-mediating Anti-HIV-1 antibodies and prognostic predictors of HIV infection
R Ahmad et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2001)
Relationship between antibody-dependent cellular cytotoxicity, plasma HIV type 1 RNA, and CD4+ lymphocyte count
DN Forthal et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2001)
Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression
L Ruiz et al.
AIDS (2000)
Share Paper
